
SP02. Treatment Approaches to Tardive Dyskinesia
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Dr. Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP, is a Board-Certified Psychiatric Mental Health Nurse Practitioner and the Associate Medical Director at Neurocrine Biosciences, in San Diego, California.
Dr. Kaylee Mehlman, PharmD, RPh, BCGP, FASCP, is a Board-Certified Geriatric Pharmacist and Long-Term Care Clinical Practice Liaison for Neurocrine Biosciences in the Northeast.
This podcast is an educational program sponsored and co-developed by Neurocrine Biosciences.
Neurocrine Biosciences is a pioneering company with over 30 years of experience dedicated to discovering and developing life-changing treatments for neurological, neuroendocrine, and neuropsychiatric disorders. Learn more: https://www.neurocrine.com/
Discover GAPNA: https://www.gapna.org/
Production management by Anthony J. Jannetti, Inc., for the Gerontological Advanced Practice Nurses Association.
Opening Music by:
Optimistic / Inspirational by Mixaund | https://mixaund.bandcamp.com
Music promoted by https://www.free-stock-music.com
Closing Music by:
Scott Holmes.
http://www.scottholmesmusic.com
Pas encore de commentaire